Saturday, June 20, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 375 of 1,261
  1. US 10874752

    MIBG analogs and uses thereof

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Dec 29, 2020 · Expires Dec 24, 2040

    granted
  2. US 10874768

    Drug eluting medical device

    Covidien LP · Granted Dec 29, 2020 · Expires Dec 24, 2040

    granted
  3. US 10874840

    Preparation comprising exanatide for delivery into a lumen of the intestinal tract

    Rani Therapeutics, LLC · Granted Dec 29, 2020 · Expires Dec 24, 2040

    granted
  4. US 10875839

    Somatostatin modulators and uses thereof

    CRINETICS PHARMACEUTICALS, INC. · Granted Dec 29, 2020 · Expires Dec 24, 2040

    granted
  5. US 10874727

    Inducible regulatory t-cell generation for hematopoietic transplants

    Regents of the University of Minnesota · Granted Dec 29, 2020 · Expires Dec 24, 2040

    granted
  6. US 10874719

    Nucleotide phosphate dissipation as a treatment for vascular disorders

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Dec 29, 2020 · Expires Dec 24, 2040

    granted
  7. US 10874745

    Antimicrobial peptides and methods of treating gram-negative pathogens: polar and non-polar face analogs

    The Regents of the University of Colorado, a Body Corporate · Granted Dec 29, 2020 · Expires Dec 24, 2040

    granted
  8. US 10874743

    IRAK degraders and uses thereof

    Kymera Therapeutics, Inc. · Granted Dec 29, 2020 · Expires Dec 24, 2040

    granted
  9. US 10875855

    Inhibitors of influenza viruses replication

    Vertex Pharmaceuticals Incorporated · Granted Dec 29, 2020 · Expires Dec 24, 2040

    granted
  10. US 10874678

    Selective high-affinity polydentate ligands and methods of making such

    The Regents of the University of California · Granted Dec 29, 2020 · Expires Dec 24, 2040

    granted
  11. US 10874672

    Methods for treating Huntington's disease

    PTC THERAPEUTICS, INC. · Granted Dec 29, 2020 · Expires Dec 24, 2040

    granted
  12. US 10874659

    Iloperidone metabolite for use in the treatment of psychiatric disorders

    VANDA PHARMACEUTICALS INC. · Granted Dec 29, 2020 · Expires Dec 24, 2040

    granted
  13. US 10874638

    Methods and compositions for modulating hormone levels

    Ligand Pharmaceuticals Incorporated · Granted Dec 29, 2020 · Expires Dec 24, 2040

    granted
  14. US 10874643

    5HT agonists for treating disorders

    The Regents of the University of California · Granted Dec 29, 2020 · Expires Dec 24, 2040

    granted
  15. US 10874635

    Tocotrienol compositions

    First Tech International Limited · Granted Dec 29, 2020 · Expires Dec 24, 2040

    granted
  16. US 10874648

    Methods for the administration of certain VMAT2 inhibitors

    Neurocrine Biosciences, Inc. · Granted Dec 29, 2020 · Expires Dec 24, 2040

    granted
  17. US 10874631

    Altertoxin II as a selective inhibitor of Ewing family of tumor cells

    The Board of Regents of the University of Texas System · Granted Dec 29, 2020 · Expires Dec 24, 2040

    granted
  18. US 10874334

    Methods and systems for quantification of blood-brain barrier permeation of glycosylated peptides

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Dec 29, 2020 · Expires Dec 24, 2040

    granted
  19. US 10874610

    Extracellular vesicle-based diagnostics and engineered exosomes for targeted therapeutics against cancer

    Northwestern University · Granted Dec 29, 2020 · Expires Dec 24, 2040

    granted
  20. US 10874622

    Dual assembly nanoparticles

    The Board of Regents of the University of Texas System · Granted Dec 29, 2020 · Expires Dec 24, 2040

    granted
  21. US 10874092

    Humanized skeletal muscle

    Regents of the University of Minnesota · Granted Dec 29, 2020 · Expires Dec 24, 2040

    granted
  22. US 10876118

    Method for expression of small antiviral RNA molecules with reduced cytotoxicity within a cell

    The Regents of the University of California · Granted Dec 29, 2020 · Expires Dec 24, 2040

    granted
  23. US 10875894

    Multimeric bicyclic peptide ligands

    BicycleTx Limited · Granted Dec 29, 2020 · Expires Dec 24, 2040

    granted
  24. US 10874687

    Highly active compounds against COVID-19

    Atea Pharmaceuticals, Inc. · Granted Dec 29, 2020 · Expires Dec 24, 2040

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.